Repligen (RGEN)
(Delayed Data from NSDQ)
$124.38 USD
+4.99 (4.18%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $124.42 +0.04 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Repligen Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
RGEN 124.38 +4.99(4.18%)
Will RGEN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RGEN
Do Options Traders Know Something About Repligen Stock We Don't?
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
RGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Repligen (RGEN) Lags Q2 Earnings Estimates
Here's Why Repligen (RGEN) is a Strong Growth Stock
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't?
Other News for RGEN
Is RGEN showing upside potential? Directional Movement Crossover Bullish shows up after sinking 0.3%
Regenera Inc. Announces Private Placement to Raise $236,192
Is RGEN likely to continue higher? Pocket Pivot shows up after rallying 5.28%
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Repligen (RGEN) and Exelixis (EXEL)
NR7 appears for RGEN after 0.18% move